|
During this orientation, the Winn CDA Team, will walk you through the application review process, the grading rubric, and go over expectations so that reviewers can get started with the review of…
|
|
The Robert A. Winn Diversity in Clinical Trials Award ProgramWinn Career Development Award (Winn CDA)Cohort 2Scholar Forum #13Date: 5/24/13Topic: Community Health Centers and Clinical TrialsPresented…
|
|
Palliative Care ECHO: Palliating Cancer-Associated Anorexia/Cachexia: Sated but not Satisfied | May 24, 2023 Presented by Paul Donegan, MD Hospice and Palliative Medicine Fellowship, UVA Objectives…
|
|
The Robert A. Winn Diversity in Clinical Trials Award ProgramWinn Career Development Award (Winn CDA)Cohort 2Scholar Forum #12Date: 5/10/23Topic: Research EthicsPresented by: Kenneth W. Goodman, PhD,…
|
|
The Robert A. Winn Diversity in Clinical Trials Award
Program
Winn Career Development Award (Winn CDA)
Cohort 2
Scholar Forum #11
Date: 04/26/23
Topic: Biostatistics II
Presented…
|
|
|
|
|
|
Palliative Care ECHO: Olanzapine and its use in palliative care and medicine | April 19, 2023 Presented by Naimish Mehta, MD Hospice and Palliative Medicine Fellowship, UVA Objectives Describe the…
|
|
The Robert A. Winn Diversity in Clinical Trials Award
Program
Winn Career Development Award (Winn CDA)
Cohort 2
Scholar Forum #10
Date: 4/12/23
Topic: Biostatistics IPresented by: Yu…
|
|
|
|
Winn CDA Canvas FAQs & How-To Slide Deck A short, optional FAQ and How-To session on all things Canvas. Walkthrough on accessing all of the files, videos, surveys, announcements and…
|
|
The Robert A. Winn Diversity in Clinical Trials Award
Program
Winn Career Development Award (Winn CDA)
Cohort 2
Scholar Forum #9
Date: 3/29/23
Topic: Statistical Methods in…
|
|
Palliative Care ECHO: Malignant Bowel Obstruction (Update) | March 29, 2023 Presented by Zainab Fatima, MD Hospice and Palliative Medicine Fellowship, VCU Health Objectives: 1. Understand the…
|
|
Board of Visitors Academic and Health Affairs Committee Meeting from March 23rd, 2023
|
|
|
|
|